Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Composite image showing man in white shirt on left, woman in dress and cardigan on right

Dr Ross Chapman, an Associate Professor and group leader of the Recombination mechanisms in immunity and cancer group at the MRC Molecular Haematology Unit has been awarded a Senior Cancer Research Fellowship of £2.1m by Cancer Research UK. The 6-year project will support research exploring mechanisms underpinning distinct manifestations of Homologous Recombination deficiency in cancer.

Dr Sarah Gooding, a Clinician Scientist in the Chapman Group has also been awarded a Clinician Scientist Fellowship of ~£1.2m by Cancer Research UK for a 5-year project to research exploiting recurrent chromosome copy number alteration (CNA)-driven defects in the treatment of Multiple Myeloma.

‘I am delighted and very excited to have been awarded a 5 year CRUK Clinician Scientist Fellowship; says Dr Gooding. 'Multiple Myeloma is bone marrow cancer which sadly remains incurable. Building on my previous work showing how myeloma genetic changes can affect drug treatment outcomes, this award will support me in investigating how we can implement genetics-guided treatment of high-risk and drug-resistant myeloma to improve patient outcomes, and how we might therapeutically exploit some of the vulnerabilities that are specific to high-risk myelomas. Thank you CRUK.’

Many congratulations to Professor Chapman and Dr Gooding on their awards.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

James Davies named as Lister Research Prize Fellow

James Davies has been named as one of eight researchers selected for the 2022 Fellowship scheme.

Understanding the interplay of dietary iron, anaemia and the immune system

Four related projects aim to unravel how the iron we eat shapes how the immune system develops and responds to vaccines.

Six new Associate Professor titles at RDM

Graham Collins, Betty Raman, Susie Shapiro, Christopher Toepfer, Stephen Twigg, and Adam Wilkinson have all been awarded Associate Professor titles

Building on the pandemic experience

Dr Susie Shapiro on her experience of working through the pandemic, and how she is building on it.

Two NHSBT research units launch at RDM

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford, with two of them led by RDM researchers.